Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $191M (100.0% shares, 0.0% debt)

Holdings (26)

— AMRYT PHARMA PLC - SPNR ADR 17.7%

Value $33.94M Shares 2,797,744 Est. Cost $13.38 Unrealized —

— CHIASMA INC 16.7%

Value $32.02M Shares 6,770,000 Est. Cost $3.69 Unrealized —

— CTI BIOPHARMA CORP 10.0%

Value $19.08M Shares 7,632,530 Est. Cost $2.48 Unrealized —

— ADAMAS PHARMACEUTICALS INC 7.4%

Value $14.23M Shares 2,694,295 Est. Cost $4.78 Unrealized —

— CATALYST BIOSCIENCES INC 7.0%

Value $13.32M Shares 3,076,376 Est. Cost $4.78 Unrealized —

— STRONGBRIDGE BIOPHARMA PLC 5.1%

Value $9.818M Shares 3,305,617 Est. Cost $2.85 Unrealized —

OVID OVID THERAPEUTICS INC 4.1%

Value $7.82M Shares 2,000,000 Est. Cost $3.32 Unrealized +18.8%

— CONFORMIS INC 4.0%

Value $7.62M Shares 6,626,085 Est. Cost $1.04 Unrealized —

— AFFIMED NV 3.8%

Value $7.225M Shares 850,000 Est. Cost $6.95 Unrealized —

— APOLLO ENDOSURGERY INC 3.2%

Value $6.174M Shares 762,183 Est. Cost $3.98 Unrealized —

XOMA XOMA CORP 2.9%

Value $5.611M Shares 165,041 Est. Cost $20.24 Unrealized +65.4%

CELC CELCUITY INC 2.7%

Value $5.255M Shares 218,951 Est. Cost $20.00 Unrealized +28.7%

— YUMANITY THERAPEUTICS INC 2.7%

Value $5.149M Shares 441,959 Est. Cost $16.28 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.5%

Value $4.792M Shares 200,000 Est. Cost $26.28 Unrealized -0.4%

— IVERIC BIO INC 1.7%

Value $3.265M Shares 517,445 Est. Cost $1.92 Unrealized —

— ANGION BIOMEDICA CORP 1.5%

Value $2.901M Shares 222,836 Est. Cost $16.08 Unrealized —

— GAMIDA CELL LTD 1.5%

Value $2.843M Shares 443,507 Est. Cost $7.50 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS INC 1.4%

Value $2.732M Shares 303,851 Est. Cost $11.25 Unrealized -14.7%

XGN EXAGEN INC 1.3%

Value $2.541M Shares 169,542 Est. Cost $17.82 Unrealized -13.9%

— CIDARA THERAPEUTICS INC 1.3%

Value $2.447M Shares 1,211,286 Est. Cost $2.02 Unrealized —

DMAC DIAMEDICA THERAPEUTICS INC 1.0%

Value $1.869M Shares 419,942 Est. Cost $4.96 Unrealized +65.5%

— CONTRAFECT CORP 0.2%

Value $296K Shares 67,208 Est. Cost $4.80 Unrealized —

— NEUBASE THERAPEUTICS INC 0.1%

Value $149K Shares 31,070 Est. Cost $4.80 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 0.1%

Value $125K Shares 46,886 Est. Cost $3.61 Unrealized -23.8%

— APPLIED GENETIC TECHNOLOGIES 0.0%

Value $4,000 Shares 1,000 Est. Cost $5.07 Unrealized —

SCYX SCYNEXIS INC 0.0%

Value $1,000 Shares 100 Est. Cost $7.89 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AMRYT PHARMA PLC - SPNR ADR	2,797,744	$33.94M	17.7%	$13.38	—	SPONSORED ADS	03217L106
—	CHIASMA INC	6,770,000	$32.02M	16.7%	$3.69	—	COM	16706W102
—	CTI BIOPHARMA CORP	7,632,530	$19.08M	10.0%	$2.48	—	COM	12648L601
—	ADAMAS PHARMACEUTICALS INC	2,694,295	$14.23M	7.4%	$4.78	—	COM	00548A106
—	CATALYST BIOSCIENCES INC	3,076,376	$13.32M	7.0%	$4.78	—	COM NEW	14888D208
—	STRONGBRIDGE BIOPHARMA PLC	3,305,617	$9.818M	5.1%	$2.85	—	SHS USD	G85347105
OVID	OVID THERAPEUTICS INC	2,000,000	$7.82M	4.1%	$3.32	+18.8%	COM	690469101
—	CONFORMIS INC	6,626,085	$7.62M	4.0%	$1.04	—	COM	20717E101
—	AFFIMED NV	850,000	$7.225M	3.8%	$6.95	—	COM	N01045108
—	APOLLO ENDOSURGERY INC	762,183	$6.174M	3.2%	$3.98	—	COM	03767D108
XOMA	XOMA CORP	165,041	$5.611M	2.9%	$20.24	+65.4%	COM NEW	98419J206
CELC	CELCUITY INC	218,951	$5.255M	2.7%	$20.00	+28.7%	COM	15102K100
—	YUMANITY THERAPEUTICS INC	441,959	$5.149M	2.7%	$16.28	—	COM	98872L102
KALV	KALVISTA PHARMACEUTICALS INC	200,000	$4.792M	2.5%	$26.28	-0.4%	COM	483497103
—	IVERIC BIO INC	517,445	$3.265M	1.7%	$1.92	—	COM	46583P102
—	ANGION BIOMEDICA CORP	222,836	$2.901M	1.5%	$16.08	—	COM	03476J107
—	GAMIDA CELL LTD	443,507	$2.843M	1.5%	$7.50	—	SHS	M47364100
EYPT	EYEPOINT PHARMACEUTICALS INC	303,851	$2.732M	1.4%	$11.25	-14.7%	COM NEW	30233G209
XGN	EXAGEN INC	169,542	$2.541M	1.3%	$17.82	-13.9%	COM	30068X103
—	CIDARA THERAPEUTICS INC	1,211,286	$2.447M	1.3%	$2.02	—	COM	171757107
DMAC	DIAMEDICA THERAPEUTICS INC	419,942	$1.869M	1.0%	$4.96	+65.5%	COM NEW	25253X207
—	CONTRAFECT CORP	67,208	$296K	0.2%	$4.80	—	COM NEW	212326300
—	NEUBASE THERAPEUTICS INC	31,070	$149K	0.1%	$4.80	—	COM	64132K102
CRVS	CORVUS PHARMACEUTICALS INC	46,886	$125K	0.1%	$3.61	-23.8%	COM	221015100
—	APPLIED GENETIC TECHNOLOGIES	1,000	$4,000	0.0%	$5.07	—	COM	03820J100
SCYX	SCYNEXIS INC	100	$1,000	0.0%	$7.89	0.0%	COM NEW	811292200